Literature DB >> 16430453

Protein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism.

M J Kovacs1, J Kovacs, J Anderson, M A Rodger, K Mackinnon, P S Wells.   

Abstract

In the 50% of cases of acute idiopathic venous thromboembolism, laboratory testing for inherited causes is often performed. Most physicians are under the impression that assays for protein C and protein S should not be measured at the time of diagnosis because of a high false positive rate. We performed a prospective cohort study from two outpatient thromboembolism clinics on consecutive patients with an objectively confirmed diagnosis of first acute idiopathic venous thromboembolism. Assays for protein C and protein S were performed prior to the initiation of oral anticoagulation therapy and within 24 h of diagnosis of venous thromboembolism. Abnormal results were repeated when patients discontinued oral anticoagulant therapy. Of 253 patients tested for both protein C and protein S, 229 (91%; 95% confidence interval 87-94%) were negative and 484 of 508 (95%) tests were normal. Of the 24 initial abnormal results, 21 were repeated and 10 (48%; 95% confidence interval 26-70%) were still abnormal. Overall, 97.8% of initial protein C and protein S results were accurate. If protein C and protein S are measured at the time of diagnosis of acute venous thromboembolism, the majority of the results will be normal and false positives are uncommon.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430453     DOI: 10.1111/j.1365-2257.2006.00746.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  2 in total

1.  Normal levels of protein C and protein S tested in the acute phase of a venous thromboembolic event are not falsely elevated.

Authors:  Leonard Minuk; Alejandro Lazo-Langner; Judy Kovacs; Melinda Robbins; Bev Morrow; Michael Kovacs
Journal:  Thromb J       Date:  2010-05-18

2.  Congenital protein C deficiency and thrombosis in a dog.

Authors:  Darren Kelly; Florence Juvet; Gary Moore
Journal:  J Vet Intern Med       Date:  2020-04-11       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.